VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen

Journal of Cellular Physiology

Volumn 222, Issue 1, 2010, Pages 230-237

  Defawe, Olivier D ^a,d   Kim, Sarah ^a   Chen, Lihua ^a   Huang, Daming ^a   Kenagy, Richard D ^a   Renné, Thomas ^b,c   Walter, Ulrich ^b   Daum, Günter ^a   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COLLAGEN; NITRIC OXIDE; SERINE DERIVATIVE; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; GENE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; STIMULATION; WILD TYPE;

ACTINS; ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL SHAPE; CELL SURFACE EXTENSIONS; COLLAGEN; GELS; HUMANS; MICE; MICROFILAMENT PROTEINS; MUTANT PROTEINS; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN TRANSPORT;

EID: 73949083864     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21942     Document Type: Article

References (52)

1. Bachmann C, Fischer L, Walter U, Reinhard M. 1999. The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation. J Biol Chem 274:23549-23557.
2. Barzik M, Kotova TI, Higgs HN, Hazelwood L, Hanein D, Gertler FB, Schafer DA. 2005. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem 280:28653-28662.
3. Bear JE, Svitkina TM, Krause M, Schafer DA, Loureiro JJ, Strasser GA, Maly IV, Chaga OY, Cooper JA, Borisy GG, Gertler FB. 2002. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 109:509-521.
4. Benz PM, Blume C, Moebius J, Oschatz C, Schuh K, Sickmann A, Walter U, Feller SM, Renné T. 2008. Cytoskeleton assembly at endothelial cell-cell contacts is regulated by αII-spectrin-VASP complexes. J Cell Biol 180:205-219.
5. Blume C, Benz PM, Walter U, Ha J, Kemp BE, Renné T. 2007. AMP-activated protein kinase impairs endothelial actin cytoskeleton assembly by phosphorylating vasodilator-stimulated phosphoprotein. J Biol Chem 282:4601-4612.
6. Brown C, Pan X, Hassid A. 1999. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: Relationship to microfilament dissociation and altered cell morphology. Circ Res 84:655-667.
7. Brown C, Lin Y, Hassid A. 2001. Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility. Am J Physiol 281:H1598-H1605.
8. Bundschu K, Walter U, Schuh K. 2006. The VASP-Spred-Sprouty domain puzzle. J Biol Chem 281:36477-36481.
9. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U. 1994. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 269:14509-14517.
10. Chang Y, Ceacareanu B, Dixit M, Sreejayan N, Hassid A. 2002. Nitric oxide-induced motility in aortic smooth muscle cells: Role of protein tyrosine phosphatase SHP-2 and GTP-binding protein Rho. Circ Res 91:390-397.
11. Chen L, Daum G, Forough R, Clowes M, Walter U, Clowes AW. 1998. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res 82:862-870.
12. Chen L, Daum G, Chitaley K, Coats SA, Bowen-Pope DF, Eigenthaler M, Thumati NR, Walter U, Clowes AW. 2004. Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24:1403-1408.
13. Chereau D, Dominguez R. 2006. Understanding the role of the G-actin-binding domain of Ena/VASP in actin assembly. J Struct Biol 155:195-201.
14. Chitaley K, Chen L, Galler A, Walter U, Daum G, Clowes AW. 2004. Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C. FEBS Lett 556:211-215.
15. Cohen RA. 1995. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 38:105-128.
16. Drees B, Friederich E, Fradelizi J, Louvard D, Beckerle MC, Golsteyn RM. 2000. Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins. J Biol Chem 275:22503-22511.
17. Dubey RK, Jackson EK, Luscher TF. 1995. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest 96:141-149.
18. Ferron F, Rebowski G, Lee SH, Dominguez R. 2007. Structural basis for the recruitment of profilin-actin complexes during filament elongation by Ena/VASP. EMBO J 26:4597-4606.
19. Galler AB, Garcia Arguinzonis MI, Baumgartner W, Kuhn M, Smolenski A, Simm A, Reinhard M. 2006. VASP-dependent regulation of actin cytoskeleton rigidity, cell adhesion, and detachment. Histochem Cell Biol 125:457-474.
20. Garg UC, Hassid A. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777.
21. Harbeck B, Huttelmaier S, Schluter K, Jockusch BM, Illenberger S. 2000. Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interactionwith actin. J Biol Chem 275:30817-30825.
22. Hassid A, Yao J, Huang S. 1999. NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation. Am J Physiol 277:H1014-H1026.
23. Hofmann F, Ammendola A, Schlossmann J. 2000. Rising behind NO: cGMP-dependent protein kinases. J Cell Sci 113:1671-1676.
24. Huttelmaier S, Harbeck B, Steffens O, Messerschmidt T, Illenberger S, Jockusch BM. 1999. Characterization of the actin binding properties of the vasodilator-stimulated phosphoprotein VASP. FEBS Lett 451:68-74.
25. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. 2001. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 98:4202-4208.
26. Kanda S, Kuzuya M, Ramos MA, Koike T, Yoshino K, Ikeda S, Iguchi A. 2000. Matrix metalloproteinase and alphavbeta3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice. Arterioscler Thromb Vasc Biol 20:998-1005.
27. Kragtorp KA, Miller JR. 2006. Regulation of somitogenesis by Ena/VASP proteins and FAK during Xenopus development. Development 133:685-695.
28. Garcia-Arguinzonis MI, Galler AB, Walter U, Reinhard M, Simm A. 2002. Increased spreading, Rac/p21-activated kinase (PAK) activity, and compromised cell motility in cells deficient in vasodilator-stimulated phosphoprotein (VASP). J Biol Chem 277:45604-45610.
29. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. 2003. Ena/VASP proteins: Regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19:541-564.
30. Kühnel K, Jarchau T, Wolf E, Schlichting I, Walter U, Wittinghofer A, Strelkov SV. 2004. The VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat. Proc Natl Acad Sci USA 101:17027-17032.
31. Kwiatkowski AV, Gertler FB, Loureiro JJ. 2003. Function and regulation of Ena/VASP proteins. Trends Cell Biol 13:386-392.
32. Lincoln TM, Cornwell TL. 1993. Intracellular cyclic GMP receptor proteins. FASEB J 7:328-338.
33. Lindsay SL, Ramsey S, Aitchison M, Renné T, Evans TJ. 2007. Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239. J Cell Sci 120:3011-3021.
34. Loscalzo J, Welch G. 1995. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38:87-104.
35. Loureiro JJ, Rubinson DA, Bear JE, Baltus GA, Kwiatkowski AV, Gertler FB. 2002. Critical roles of phosphorylation and actin binding motifs, but not the central proline-rich region, for Ena/vasodilator-stimulated phosphoprotein (VASP) function during cellmigration. Mol Biol Cell 13:2533-2546.
36. Massberg S, Gruner S, Konrad I, Garcia Arguinzonis MI, Eigenthaler M, Hemler K, Kersting J, Schulz C, Muller I, Besta F, Nieswandt B, Heinzmann U, Walter U, Gawaz M. 2004. Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood 103:136-142.
37. Miller AD, Rosman GJ. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
38. Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smolenski A, Walter U, Skatchkov M, Meinertz T, Munzel T. 2000. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res 87:999-1005.
39. Pelletier S, Julien C, Popoff MR, Lamarche-Vane N, Meloche S. 2005. Cyclic AMP induces morphological changes of vascular smooth muscle cells by inhibiting a Rac-dependent signaling pathway. J Cell Physiol 204:412-422.
40. Reinhard M, Giehl K, Abel K, Haffner C, Jarchau T, Hoppe V, Jockusch BM, Walter U. 1995. The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J 14:1583-1589.
41. Reinhard M, Jarchau T, Walter U. 2001. Actin-based motility: Stop and go with Ena/VASP proteins. Trends Biochem Sci 26:243-249.
42. Samarin S, Romero S, Kocks C, Didry D, Pantaloni D, Carlier MF. 2003. How VASP enhances actin-based motility. J Cell Biol 163:131-142.
43. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. 1996. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78:225-230.
44. Schafer A, Burkhardt M, Vollkommer T, Bauersachs J, Munzel T, Walter U, Smolenski A. 2003. Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta. Biochem Pharmacol 65:397-405.
45. Schirenbeck A, Arasada R, Bretschneider T, Stradal TE, Schleicher M, Faix J. 2006. The bundling activity of vasodilator-stimulated phosphoprotein is required for filopodium formation. Proc Natl Acad Sci USA 103:7694-7699.
46. Smolenski A, Bachmann C, Reinhard K, Honig-Liedl P, Jarchau T, Hoschuetzky H, Walter U. 1998. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273:20029-20035.
47. Smolenski A, Poller W, Walter U, Lohmann SM. 2000. Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I. J Biol Chem 275:25723-25732.
48. Sreejayan N, Lin Y, Hassid A. 2002. NO attenuates insulin signaling and motility in aortic smooth muscle cells via a protein tyrosine phosphatase 1B-mediated mechanism. Arterioscler Thromb Vasc Biol 22:1086-1092.
49. Tolic-Norrelykke IM, Wang N. 2005. Traction in smooth muscle cells varies with cell spreading. J Biomech 38:1405-1412.
50. Umans JG, Levi R. 1995. Nitric oxide in the regulation of blood flow and arterial pressure. Annu Rev Physiol 57:771-790.
51. Walders-Harbeck B, Khaitlina SY, Hinssen H, Jockusch BM, Illenberger S. 2002. The vasodilator-stimulated phosphoprotein promotes actin polymerisation through direct binding to monomeric actin. FEBS Lett 529:275-280.
52. Zhuang S, Nguyen GT, Chen Y, Gudi T, Eigenthaler M, Jarchau T, Walter U, Boss GR, Pilz RB. 2004. Vasodilator-stimulated phosphoprotein activation of serum-response element-dependent transcription occurs downstream of RhoA and is inhibited by cGMP-dependent protein kinase phosphorylation. J Biol Chem 279:10397-10407.